Fed Circ injects new life into Mylan dispute

07-11-2023

Muireann Bolger

Fed Circ injects new life into Mylan dispute

ricochet64 / Shutterstock.com

Appeals court faults lower court’s claim construction and its reliance on intrinsic evidence alone | Court emphasises that extrinsic evidence is needed in litigation over heart disease drug.


US Court of Appeals for the Federal Circuit, Mylan, epoprostenol, heart disease, litigation, generics, infringement

LSIPR